Skip to main content

Diametric Capital, LP

SEC CIK
0001719087
Latest filing
Aug 14, 2026

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings

Shares (Q2 2026)
9,295
Value
$692.3K
% of portfolio
0.1%
Quarters held
2
Since Q2 2024
Holdings of BBIO by Diametric Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,295$692.3K0.1%+9,295NewHolders
Q3 20240$00.0%−12,076−100.0%Sold outHolders
Q2 202412,076$305.9K0.2%+12,076NewHolders